KEELIE JOHNSTON: Open Payments
NPI 1386344471 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 35 payments from 12 companies in 2025. Trend: 2023 $490 · 2024 $618 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $183 |
| ABBVIE INC. | 14 | $163 |
| UCB, Inc. | 5 | $113 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Galderma Laboratories, L.P. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Organon LLC | 1 | $17 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, Sotyktu, NEMLUVIO, EBGLYSS, TREMFYA.
Industry payments across TX — which companies pay providers there.
